About this trial
evaluate the degree of association, and the predictive accuracy of the REPS (as a predictive tool) compared with the TOFr as a quantitative assessment tool for (rNMB) in surgical patients in the early postoperative phase. The TOFr will be measured at 0, 15, 30, 45, and 60 min after extubation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age group 18-65 years old
Both genders
Patients with American Society of Anesthesiologist physical status classification of 1 or 2.
Disqualifiers
Patients who are less than 18 years old or more than 65 years old.
Patients with planned scheduled recovery in the intensive care unit or if more than 10 minutes had elapsed since tracheal extubation until NMB monitoring at the PACU.
Patients on medications that interfere with muscle activity.
Known allergy to neuromuscular blocking agents.
Trial population
Patients who will be scheduled to undergo elective surgical procedures requiring the use of neuromuscular blocking drugs.
Trial design
Cohort
Prospective
Treatments tested in this trial
residual neuromuscular block risk prediction score
Diagnostic testit is a clinical tool designed to estimate the likelihood of residual neuromuxcular blockade in postoperative patients
Treatment groups
Trial outcomes
Primary outcomes
correlation between residual neuromuscular block risk prediction score and train of four
Sponsors and contacts
Click on the lead sponsor to view all of their trials.